Charles R. Pound

7.6k total citations · 4 hit papers
42 papers, 6.0k citations indexed

About

Charles R. Pound is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Charles R. Pound has authored 42 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 14 papers in Rheumatology and 9 papers in Molecular Biology. Recurrent topics in Charles R. Pound's work include Prostate Cancer Diagnosis and Treatment (25 papers), Prostate Cancer Treatment and Research (23 papers) and Urologic and reproductive health conditions (14 papers). Charles R. Pound is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (25 papers), Prostate Cancer Treatment and Research (23 papers) and Urologic and reproductive health conditions (14 papers). Charles R. Pound collaborates with scholars based in United States, Brazil and Israel. Charles R. Pound's co-authors include Alan W. Partin, Jonathan I. Epstein, Patrick C. Walsh, J. Quentin Clemens, Misop Han, Thomas J. Polascik, Steven A. Bigler, Xinchun Zhou, Jay D. Pearson and Patricia K. Landis and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Charles R. Pound

42 papers receiving 5.7k citations

Hit Papers

Natural History of Progression After PSA Elevation Follow... 1993 2026 2004 2015 1999 2001 1997 1993 500 1000 1.5k 2.0k

Peers

Charles R. Pound
Leslie A. Mangold United States
Charles R. Pound
Citations per year, relative to Charles R. Pound Charles R. Pound (= 1×) peers Leslie A. Mangold

Countries citing papers authored by Charles R. Pound

Since Specialization
Citations

This map shows the geographic impact of Charles R. Pound's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles R. Pound with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles R. Pound more than expected).

Fields of papers citing papers by Charles R. Pound

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles R. Pound. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles R. Pound. The network helps show where Charles R. Pound may publish in the future.

Co-authorship network of co-authors of Charles R. Pound

This figure shows the co-authorship network connecting the top 25 collaborators of Charles R. Pound. A scholar is included among the top collaborators of Charles R. Pound based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles R. Pound. Charles R. Pound is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pound, Charles R., et al.. (2017). Benign Testis Mass After Viral Infection. Urology Case Reports. 12. 4–5. 2 indexed citations
2.
Zhou, Xinchun, Jinghe Mao, Junmei Ai, et al.. (2012). Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics. PLoS ONE. 7(11). e48889–e48889. 168 indexed citations
3.
Zhou, Xinchun, et al.. (2011). The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer. Experimental and Molecular Pathology. 92(1). 105–110. 68 indexed citations
4.
Cannon, Glenn M., Charles R. Pound, Douglas Landsittel, et al.. (2004). Perineural invasion in prostate cancer biopsies is not associated with higher rates of positive surgical margins. The Prostate. 63(4). 336–340. 23 indexed citations
5.
Cannon, Glenn M., Patrick C. Walsh, Alan W. Partin, & Charles R. Pound. (2003). Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer. Urology. 62. 2–8. 26 indexed citations
6.
Gretzer, Matthew, Jonathan I. Epstein, Charles R. Pound, Patrick C. Walsh, & Alan W. Partin. (2002). Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence. Urology. 60(6). 1034–1039. 21 indexed citations
7.
Han, Misop, Alan W. Partin, Charles R. Pound, Jonathan I. Epstein, & Patrick C. Walsh. (2001). LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY. Urologic Clinics of North America. 28(3). 555–565. 821 indexed citations breakdown →
8.
Laufer, Menachem, Charles R. Pound, Michael A. Carducci, & Mario A. Eisenberger. (2000). Management of patients with rising prostate-specific antigen after radical prostatectomy. Urology. 55(3). 309–315. 31 indexed citations
9.
Pannek, Jürgen, Yegappan Lakshmanan, Charles R. Pound, et al.. (1999). Nuclear shape and nuclear matrix protein composition in prostate and seminal vesicles. Urology. 54(5). 934–939. 2 indexed citations
10.
Carducci, Michael A., Charles R. Pound, Jonathan I. Epstein, et al.. (1999). Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. Urology. 53(1). 44–49. 36 indexed citations
11.
Walsh, Patrick C., et al.. (1999). Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology. 53(4). 752–756. 57 indexed citations
12.
Partin, Alan W., Charles R. Pound, Mario A. Eisenberger, et al.. (1999). PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME (PSADT), GLEASON SCORE AND THE TIME TO PSA RECURRENCE FOLLOWING RADICAL PROSTATECTOMY PREDICTS TIME TO DISTANT PROGRESSION. The Journal of Urology. 175–175. 1 indexed citations
13.
Simon, Inpakala, Charles R. Pound, Alan W. Partin, J. Quentin Clemens, & William A. Christens‐Barry. (1998). Automated image analysis system for detecting boundaries of live prostate cancer cells. Cytometry. 31(4). 287–294. 25 indexed citations
14.
Polascik, Thomas J., Alan W. Partin, Charles R. Pound, & Fray F. Marshall. (1998). Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis. Urology. 52(6). 995–999. 7 indexed citations
15.
Pound, Charles R., et al.. (1997). PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY. Urologic Clinics of North America. 24(2). 395–406. 484 indexed citations breakdown →
16.
Pound, Charles R., Patrick C. Walsh, Jonathan I. Epstein, Daniel W. Chan, & Alan W. Partin. (1997). Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer. World Journal of Urology. 15(6). 373–377. 17 indexed citations
17.
Marshall, Fray F., Gary D. Steinberg, Charles R. Pound, & Alan W. Partin. (1995). Radical surgery for renal-cell carcinoma: caval neoplastic excision, adrenalectomy, lymphadenectomy, adjacent organ resection. World Journal of Urology. 13(3). 159–62. 5 indexed citations
18.
Polascik, Thomas J., Charles R. Pound, Maxwell V. Meng, Alan W. Partin, & Fray F. Marshall. (1995). Partial Nephrectomy. The Journal of Urology. 1312–1318. 5 indexed citations
19.
Partin, Alan W., Charles R. Pound, Jay D. Pearson, et al.. (1994). Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 43(5). 649–659. 328 indexed citations
20.
Pound, Charles R., et al.. (1993). Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology. 42(3). 243–248. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026